US Patent Issued to ANTECIP BIOVENTURES II on March 17 for "Compounds and combinations thereof for treating neurological and psychiatric conditions" (New York Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,078, issued on March 17, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Compounds and combinations thereof for treating neurological and psychiatric conditions" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Dosage forms, drug delivery systems, and methods related to dextromethorphan or improved therapeutic effects are disclosed. Typically, an antidepressant, such as bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan."

The patent was filed on April 17, 2025, under Application No. 19/182,010.

*For further information...